Parallel Advisors, LLC Tarsus Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 20, 2024	BUY	$11.57 - $19.63 $497 - $844	43 New	43 $0
Q2 2023 Aug 04, 2023	BUY	$11.57 - $19.63 $497 - $844	43 New	43 $0
Q3 2022 Nov 10, 2022	BUY	$14.08 - $18.5 $239 - $314	17 Added 130.77%	30 $1,000
Q2 2022 Aug 01, 2022	BUY	$11.08 - $19.08 $144 - $248	13 New	13 $0
Q4 2021 Jan 20, 2022	SELL	$21.21 - $29.68 $933 - $1,305	-44 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$21.45 - $29.22 $943 - $1,285	44 New	44 $1,000

173

43.6M

484K

4.1K

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.31B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.